Novozymes A/S (NVZMY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Novozymes A/S

    OTC: NVZMY · Real-Time Price · USD
    63.29
    0.54 (0.86%)
    At close: Sep 04, 2025, 2:05 PM

    Novozymes A/S Balance Sheet Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 280M 1.12B 1.04B 963M
    Short-Term Investments
    		 4M 40M 80M 75M
    Long-Term Investments
    		 38.7M 205M 235M -16M
    Other Long-Term Assets
    		 10M 41.64M 112M 114M
    Receivables
    		 804.6M 543.5M 532.15M 471.54M
    Inventory
    		 720.6M 3.63B 3.8B 2.99B
    Other Current Assets
    		 70.2M 947M 618M 880M
    Total Current Assets
    		 1.88B 9.46B 9.24B 7.82B
    Property-Plant & Equipment
    		 2.97B 12.32B 12.07B 10.19B
    Goodwill & Intangibles
    		 10.02B 4.53B 4.7B 5.02B
    Total Long-Term Assets
    		 13.32B 18.93B 18.74B 16.94B
    Total Assets
    		 15.2B 28.39B 27.98B 24.77B
    Account Payables
    		 423.1M 1.62B 1.87B 1.49B
    Deferred Revenue
    		 n/a n/a 138M 163M
    Short-Term Debt
    		 266.4M 3.04B 2.92B 1.98B
    Other Current Liabilities
    		 337.9M 1.65B 1.36B 3.21B
    Total Current Liabilities
    		 1.09B 7.26B 6.96B 5.67B
    Long-Term Debt
    		 1.53B 4.33B 3.62B n/a
    Other Long-Term Liabilities
    		 39.7M 2.42B 2.88B 6.53B
    Total Long-Term Liabilities
    		 2.93B 6.78B 6.79B 6.89B
    Total Liabilities
    		 4.02B 14.04B 13.76B 12.56B
    Total Debt
    		 1.8B 7.73B 411M 482M
    Common Stock
    		 936.72M 562M 562M 564M
    Retained Earnings
    		 82.28B 13.76B 13.06B 11.3B
    Comprehensive Income
    		 134.24M -339M 213M -40M
    Shareholders Equity
    		 83.35B 13.98B 13.84B 11.83B
    Total Investments
    		 42.7M 267M 315M 59M

    Add to Watchlist